Morphometric and electron-microscopic analyses of the effects of gonadotropin-releasing hormone agonists on uterine leiomyomas

Archives of Pathology and Laboratory Medicine

Volumn 122, Issue 5, 1998, Pages 442-446

  Kalir, Tamara ^a,b   Goldstein, Martin ^b   Dottino, Peter ^b   Brodman, Michael ^b   Gordon, Ron ^a   Deligdisch, Liane ^a,b   Wu, Haishan ^a   Gil, Joan ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN ANTAGONIST;

ADULT; ARTICLE; CELL DENSITY; CELL SIZE; CLINICAL ARTICLE; ELECTRON MICROSCOPY; FEMALE; HISTOPATHOLOGY; HORMONE ACTION; HUMAN; UTERUS BIOPSY; UTERUS MYOMA;

ADULT; CELL COUNT; CELL NUCLEUS; COLLAGEN; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; LEIOMYOMA; MIDDLE AGED; UTERINE NEOPLASMS;

EID: 0031836116     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Plosker GL, Brogden RN. Leuprorelin: a review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders. Drugs. 1994;48:930-967.
2. Charbonnel B. Analogs of gonadoliberin: value in physiology and therapeutics. Presse Med. 1994;23:805-811.
3. Hackenberg R, Gesenhues T, Deichert U, Duda V, Schmidt-Rhode P, Schulz KD. The response of uterine fibroids to GnRH-agonist treatment can be predicted in most cases after one month. Eur J Obstet Gynecol Reprod Biol. 1992;45:125-129.
4. Cohen D, Mazur MT, Jozefczyk MA, Badawy SZ. Hyalinization and cellular changes in uterine leiomyomata after gonadotropin releasing hormone agonist therapy. J Reprod Med. 1994;39:377-380.
5. Colgan TJ, Pendergast S, LeBlanc M. The histopathology of uterine leiomyomas following treatment with gonadotropin-releasing hormone analogues. Hum Pathol. 1993;24:1073-1077.
6. Uemura T, Mori I, Yoshimura Y, Minaguchi H. Treatment effects of GnRH agonist on the binding of estrogen and progesterone, and the histological findings of uterine leiomyomas. Asia Oceania J Obstet Gynaecol. 1991;17:315-320.
7. Upadhyahya NB, Doody MC, Googe PB. Histopathological changes in leiomyomata treated with leuprolide acetate. Fertil Steril. 1990;54:811-814.
8. Shaw RW. Mechanism of LHRH analogue action in uterine fibroids. Horm Res. 1989;32:150-153.
9. Rein MS, Barbieri RL, Welch W, Gleason RE, Caulfield JP, Friedman AJ. The concentrations of collagen-associated amino acids are higher in GnRH agonist-treated uterine myomas. Obstet Gynecol. 1993;82:901-905.
10. Sreenan JJ, Prayson RA, Biscotti CV, Thornton MH, Easley KA, Hart WR. Histopathologic findings in 107 uterine leiomyomas treated with leuprolide acetate compared with 126 controls. Am J Surg Pathol. 1996;20:427-432.
11. Gil J, Marchevsky AM, Silage DA. Applications of computerized interactive morphometry in pathology, I: tracing and generation of graphic standards. Lab Invest. 1986;54:222-227.
12. Marchevsky AM, Gil J. Applications of computerized interactive morphometry in pathology, II: a model for computer generated diagnosis. Lab Invest. 1986; 54:708-716.
13. Gil J, Barba J. Principles of stereology: computerized applications to anatomic pathology. In: Marchevsky AM, Bartels PH, eds. Image Analysis: A Primer for Pathologists. New York, NY: Raven Press; 1994:102-104.
14. Einstein A, Gil J, Wallenstein S, et al. Reproducibility and accuracy of interactive representation of procedures for image analysis in cytology. J Microscopy. 1997;188:136-148.
15. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson J. Molecular Biology of the Cell. New York, NY: Garland Publishing Inc; 1989:809.
16. Puistola U, Westerlund A, Kauppila A, Turpeenniemi-Hujanen T. Regulation of 72-kd type IV collagenase-matrix metalloproteinase-2 by estradiol and gonadotropin-releasing hormone agonist in human granulosa-lutein cells. Fertil Steril. 1995;64:81-87.